Gong M - Search Results

1

A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?

Tasch J, Gong M, Sadelain M, Heston WD. Tasch J, et al. Among authors: gong m. Crit Rev Immunol. 2001;21(1-3):249-61. Crit Rev Immunol. 2001. PMID: 11642607 Review.

2

Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers.

Gong MC, Chang SS, Sadelain M, Bander NH, Heston WD. Gong MC, et al. Cancer Metastasis Rev. 1999;18(4):483-90. doi: 10.1023/a:1006308826967. Cancer Metastasis Rev. 1999. PMID: 10855791 Review.

3

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.

Gong MC, Latouche JB, Krause A, Heston WD, Bander NH, Sadelain M. Gong MC, et al. Neoplasia. 1999 Jun;1(2):123-7. doi: 10.1038/sj.neo.7900018. Neoplasia. 1999. PMID: 10933046 Free PMC article.

4

Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy.

Gong MC, Chang SS, Watt F, O'Keefe DS, Bacich DJ, Uchida A, Bander NH, Reuter VE, Gaudin PB, Molloy PL, Sadelian M, Heston WD. Gong MC, et al. Mol Urol. 2000 Fall;4(3):217-22;discussion 223. Mol Urol. 2000. PMID: 11062377 Review.

5

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

Brentjens RJ, Latouche JB, Santos E, Marti F, Gong MC, Lyddane C, King PD, Larson S, Weiss M, Rivière I, Sadelain M. Brentjens RJ, et al. Among authors: gong mc. Nat Med. 2003 Mar;9(3):279-86. doi: 10.1038/nm827. Epub 2003 Feb 10. Nat Med. 2003. PMID: 12579196

6

Targeted elimination of prostate cancer by genetically directed human T lymphocytes.

Gade TP, Hassen W, Santos E, Gunset G, Saudemont A, Gong MC, Brentjens R, Zhong XS, Stephan M, Stefanski J, Lyddane C, Osborne JR, Buchanan IM, Hall SJ, Heston WD, Rivière I, Larson SM, Koutcher JA, Sadelain M. Gade TP, et al. Among authors: gong mc. Cancer Res. 2005 Oct 1;65(19):9080-8. doi: 10.1158/0008-5472.CAN-05-0436. Cancer Res. 2005. PMID: 16204083

7

Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research.

Elbialy A, Kappala D, Desai D, Wang P, Fadiel A, Wang SJ, Makary MS, Lenobel S, Sood A, Gong M, Dason S, Shabsigh A, Clinton S, Parwani AV, Putluri N, Shvets G, Li J, Liu X. Elbialy A, et al. Among authors: gong m. Cells. 2024 Jun 8;13(12):1005. doi: 10.3390/cells13121005. Cells. 2024. PMID: 38920635 Free PMC article. Review.

8

Introduction--translational research trends: urologic gene therapy.

Gong MC, Fair WR. Gong MC, et al. Mol Urol. 2000 Summer;4(2):37-8. doi: 10.1089/10915360050138530. Mol Urol. 2000. PMID: 12006237 No abstract available.

9

[Liangxue Jiedu Huayu Formula improves liver function of mice with acute-on-chronic liver failure by inhibiting excessive activation of the cGAS-STING signaling pathway].

Tang Q, Zhou C, Bai Z, Yao Q, Chen S, Wen X, He Z, Zhang J, Li R, Gong M. Tang Q, et al. Among authors: gong m. Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2291-2299. doi: 10.12122/j.issn.1673-4254.2024.12.04. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 39725617 Chinese.

10

Hypomagnesemia is a risk factor for acute kidney injury in patients admitted with ST-segment elevation myocardial infarction: A retrospective observational study.

Jin Y, Lin Q, Wang D, Gong M, Huang W, Shan P, Liang D. Jin Y, et al. Among authors: gong m. J Ren Nutr. 2024 Dec 24:S1051-2276(24)00291-7. doi: 10.1053/j.jrn.2024.12.006. Online ahead of print. J Ren Nutr. 2024. PMID: 39725180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,250 results

Search Page

Filters